ANGO
Price
$8.61
Change
-$0.02 (-0.23%)
Updated
May 7, 01:55 PM (EDT)
Capitalization
233.95M
63 days until earnings call
QDEL
Price
$26.24
Change
+$0.30 (+1.16%)
Updated
May 7, 02:23 PM (EDT)
Capitalization
3.14B
Earnings call today
Ad is loading...

ANGO vs QDEL

Header iconANGO vs QDEL Comparison
Open Charts ANGO vs QDELBanner chart's image
AngioDynamics
Price$8.61
Change-$0.02 (-0.23%)
Volume$100
Capitalization233.95M
QuidelOrtho
Price$26.24
Change+$0.30 (+1.16%)
Volume$2.76K
Capitalization3.14B
ANGO vs QDEL Comparison Chart
Loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANGO vs. QDEL commentary
May 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Buy and QDEL is a Hold.

Ad is loading...
COMPARISON
Comparison
May 07, 2025
Stock price -- (ANGO: $8.63 vs. QDEL: $25.94)
Brand notoriety: ANGO and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANGO: 69% vs. QDEL: 190%
Market capitalization -- ANGO: $233.95M vs. QDEL: $3.14B
ANGO [@Medical Specialties] is valued at $233.95M. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANGO and QDEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 5 bullish TA indicator(s).

  • ANGO’s TA Score: 4 bullish, 4 bearish.
  • QDEL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, QDEL is a better buy in the short-term than ANGO.

Price Growth

ANGO (@Medical Specialties) experienced а -9.92% price change this week, while QDEL (@Medical Specialties) price change was -9.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.28%. For the same industry, the average monthly price growth was +6.15%, and the average quarterly price growth was -3.86%.

Reported Earning Dates

ANGO is expected to report earnings on Jul 09, 2025.

QDEL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-0.28% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QDEL($3.14B) has a higher market cap than ANGO($234M). ANGO has higher P/E ratio than QDEL: ANGO (44.84) vs QDEL (9.76). ANGO YTD gains are higher at: -5.786 vs. QDEL (-41.773). QDEL has higher annual earnings (EBITDA): 607M vs. ANGO (-28.49M). QDEL has more cash in the bank: 167M vs. ANGO (60.9M). ANGO has less debt than QDEL: ANGO (4.73M) vs QDEL (2.61B). QDEL has higher revenues than ANGO: QDEL (3B) vs ANGO (330M).
ANGOQDELANGO / QDEL
Capitalization234M3.14B7%
EBITDA-28.49M607M-5%
Gain YTD-5.786-41.77314%
P/E Ratio44.849.76460%
Revenue330M3B11%
Total Cash60.9M167M36%
Total Debt4.73M2.61B0%
FUNDAMENTALS RATINGS
ANGO vs QDEL: Fundamental Ratings
ANGO
QDEL
OUTLOOK RATING
1..100
627
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9293
PRICE GROWTH RATING
1..100
4986
P/E GROWTH RATING
1..100
5414
SEASONALITY SCORE
1..100
19n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QDEL's Valuation (55) in the Medical Specialties industry is in the same range as ANGO (72). This means that QDEL’s stock grew similarly to ANGO’s over the last 12 months.

QDEL's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ANGO (100). This means that QDEL’s stock grew similarly to ANGO’s over the last 12 months.

ANGO's SMR Rating (92) in the Medical Specialties industry is in the same range as QDEL (93). This means that ANGO’s stock grew similarly to QDEL’s over the last 12 months.

ANGO's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for QDEL (86). This means that ANGO’s stock grew somewhat faster than QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for ANGO (54). This means that QDEL’s stock grew somewhat faster than ANGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGOQDEL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 6 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSGRX45.32N/A
N/A
Goldman Sachs Equity Income A
NAESX105.83N/A
N/A
Vanguard Small Cap Index Inv
BSCFX27.69N/A
N/A
Baron Small Cap Retail
FIDPX10.53N/A
N/A
Federated Hermes Intl Dividend Strategy
MLPAX8.13N/A
N/A
Invesco SteelPath MLP Alpha A

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
-4.32%
STRRP - ANGO
48%
Loosely correlated
-3.63%
MXCT - ANGO
37%
Loosely correlated
-0.37%
QDEL - ANGO
36%
Loosely correlated
-6.32%
HBIO - ANGO
35%
Loosely correlated
-9.06%
NVST - ANGO
35%
Loosely correlated
-3.42%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with DHR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-6.32%
DHR - QDEL
56%
Loosely correlated
-3.72%
IQV - QDEL
53%
Loosely correlated
-4.01%
RVTY - QDEL
51%
Loosely correlated
-2.60%
BIO - QDEL
51%
Loosely correlated
-3.59%
TMO - QDEL
49%
Loosely correlated
-3.61%
More